| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f8beafe15c0777c1ba9adfb27f5f954 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate |
2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb7682fc34ae0e8e1359e25e30a05ae1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e15e96f56bfb382055dfc636e9d8090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745ca3e6d1f4a2051cf0d3beaf831668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ced9d688f0329829f4e012c00208337 |
| publicationDate |
2020-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020010461-A1 |
| titleOfInvention |
Compounds, compositions, and methods for increasing cftr activity |
| abstract |
The present disclosure is directed to disclosed compounds that increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11248010-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10899751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083709-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136313-B2 |
| priorityDate |
2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |